Epidemiology and outcomes of primary sclerosing cholangitis: an Australian multicentre retrospective cohort study
Natassia Tan(The Alfred Hospital), Stuart K. Roberts(The Alfred Hospital), Nicholas Hannah(The Royal Melbourne Hospital), Kate D. Lynch(Royal Adelaide Hospital), Alastair M. Thompson(Baylor College of Medicine), Tobie Abrahams(St Vincent's Health), R. G. Madden(Royal Adelaide Hospital), John Lubel(Eastern Health), Abinash Dev(Monash Health), A. J. Nicoll(Eastern Health), Paul Gow(The University of Melbourne), T. Lee(St Vincent's Health), Z. Valaydon(Western Health), Siddharth Sood(The Royal Melbourne Hospital), Ammar Majeed(Monash University), K. Pandya(Royal Prince Alfred Hospital), K. Gazelakis(Western Health), T. Worland(Austin Health), Elliot Freeman(Alfred Health), N. Ngu(Monash Health), Sally Bell(University of Glasgow), William Kemp(Monash University), K. Liu(Royal Prince Alfred Hospital), J.-X. Ding(The University of Melbourne)
Cited by 20
Related Papers
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k
Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study
|The Lancet Oncology|2018|501
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age
|The Lancet Oncology|2021|355
Small Molecule Antagonists of the σ-1 Receptor Cause Selective Release of the Death Program in Tumor and Self-Reliant Cells and Inhibit Tumor Growth <b> <i>in Vitro</i> </b> and <b> <i>in Vivo</i> </b>
|Cancer Research|2004|165
Obeticholic acid—a new therapy in PBC and NASH
|British Medical Bulletin|2020|123